Showing results (291-300 of 1,340) with videos related to
Sort By:
Pageof 134
Neuro-Oncology Advances|April 28, 2026
Utility of dynamic 18F-fluoroethyl-L-tyrosine positron emission tomography in determining pseudoprogression from tumor recurrence in the 6 months following radiation therapy for glioblastomaKevin Jang, Patrick Horsley, Dale Bailey, et al.Neuro-Oncology Advances|April 28, 2026
Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-mutant gliomas treated with bevacizumabCollin T Le, Francesco Sanvito, Chuyin Yang, et al.Neuro-Oncology Advances|May 4, 2026
Preoperative tumor and edema volumes as predictors of ischemia and morbidity after intracranial meningioma surgerySahin Hanalioglu, Efecan Cekic, Emin Tabipoglu, et al.Neuro-Oncology Advances|May 4, 2026
Clinical characteristics and outcomes of adult IDH-mutant brainstem gliomas: Institutional case series and systematic reviewMaged T Ghoche, Kenji Miki, Fanen Yuan, et al.Neuro-Oncology Advances|May 27, 2026
Two-step awake craniotomy for diffuse supratentorial gliomasPetra Bintintan-Socaciu, Shuroq Taju, Angela Elia, et al.Neuro-Oncology Advances|June 1, 2026
Leveraging neuroscience imaging and electrophysiological assessments to decode neuron-glioma interactionsSanjeev Herr, Sena Oten, Joshua D Bernstock, et al.Neuro-Oncology Advances|June 1, 2026
Elevated neutrophil-to-lymphocyte ratio as a prognostic factor in primary central nervous system lymphomaRuba Memon, Ruju Talati, Richard Song, et al.Neuro-Oncology Advances|June 8, 2026
Intraoperative, interstitial brachytherapy in newly diagnosed brain metastases through cesium-131 collagen tile implant: A multi-institutional case seriesCarlin Chuck, Mazen Taman, Trenton Kite, et al.Neuro-Oncology Advances|August 2, 2023
Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastomaNayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.Neuro-Oncology Advances|August 7, 2023
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastomaTeresa Schmidt, Sarina Agkatsev, Jonas Feldheim, et al.Pageof 134